Esperion Therapeutics stock remains a buy as strong drug franchises, growth, and global milestones outweigh risks. Learn more ...
On track to submit GraftAssureDx™ for FDA review by year-endOn track for commitment to have 20 transplant centers globally ...
Canadian Natural Resources Limited ( CNQ:CA) Discusses Strategic Advantages, Asset Base, and Outlook at Investor Open House November 7, 2025 8:30 AM EST ...
Record operating cash flow (before working capital adjustments) for the three months ended September 30, 2025, of $101.8 ...
Barchart on MSN
Should You Buy Gitlab Stock Amid Takeover Speculation?
The market had barely begun to catch its breath when GitLab (GTLB) decided to steal the spotlight last month on Oct. 16. The ...
Year, and Adjusted EBITDA of $11.7 Million, up 34% Year-Over YearNine Month Revenue of $135.8 Million, up 11% Year-over-Year; Adjusted EBITDA ...
K92 Mining Inc. ("K92" or the "Company") (TSX: KNT; OTCQX: KNTNF) is pleased to announce financial results for the three and ...
Cryptocurrency trading is not just a niche anymore. It is becoming a serious part of mainstream finance. From PayPal (PYPL) ...
Transparency earns trust. When franchisors share clear, actionable data and coach teams to use it, operators make faster, ...
During Meta's third-quarter earnings call last week, CEO Mark Zuckerberg spent quite a bit of time detailing the company's AI ...
How thinking like a buyer of your own company creates better strategic decisions—even when you never plan to sell.
Gold price (XAU/USD) trades in positive territory around $4,050 during the early Asian session on Monday. The precious metal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback